Xenco Medical Named To TIME100, Wins 2026 Health Impact Award
KUALA LUMPUR, May 4 (Bernama) -- Xenco Medical has been named to the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health by Time Magazine.
In a statement, the medical technology company said it was the sole recipient of the health category award this year, recognising its impact on global healthcare.
According to Time Magazine, the TIME100 Most Influential Companies list highlights organisations making an extraordinary impact worldwide, while the TIME100 Impact Awards are presented to a limited number of recipients annually.
The recognition follows Xenco Medical being named the 2025 Medical Device/Diagnostics Company of the Year at the Trailblazer Awards in New York City.
“We are immensely honoured and profoundly humbled to be named the 2026 Winner of the TIME100 Impact in Health Award and a TIME100 Most Influential Company in the World.
“This recognition by TIME has only deepened our commitment to translate the promise of science into a transformative impact on the lives of our patients and their families,” said Xenco Medical Founder and Chief Executive Officer, Jason Haider.
Xenco Medical’s portfolio includes biomimetic implants, regenerative biomaterials, composite polymer surgical systems and software technologies such as artificial intelligence (AI)-enabled remote therapeutic monitoring and preoperative holographic surgical simulation.
Its platform enables surgeons to remotely monitor pain, rehabilitation adherence and motion recovery via AI-driven analytics during the bone remodelling process.
-- BERNAMA